A. ERNEST TOTH JR

Insider Reports History

Signature
/s/ Lori J. Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A. ERNEST TOTH JR:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. Chief Financial Officer Common Stock 339,366 $899,320 $2.65 09 Mar 2025 Direct
Aquestive Therapeutics, Inc. Chief Financial Officer Non-Qualified Stock Option (right to buy) 60,000 07 Mar 2025 Direct
Aquestive Therapeutics, Inc. Chief Financial Officer Non-Qualified Stock Option (right to buy) 60,000 07 Mar 2024 Direct

Insider Reports Filed by A. ERNEST TOTH JR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 07 Mar 2025 4 -$50,162 4 Chief Financial Officer 11 Mar 2025, 17:48
AQST Aquestive Therapeutics, Inc. 09 Mar 2024 1 -$57,120 4 SVP, Chief Financial Officer 12 Mar 2024, 13:47
AQST Aquestive Therapeutics, Inc. 07 Mar 2024 2 $0 4 SVP, Chief Financial Officer 11 Mar 2024, 10:36
AQST Aquestive Therapeutics, Inc. 09 Aug 2023 1 $0 4 SVP, Chief Financial Officer 09 Aug 2023, 16:30
AQST Aquestive Therapeutics, Inc. 05 May 2023 1 $0 4 SVP, Chief Financial Officer 05 May 2023, 16:00
AQST Aquestive Therapeutics, Inc. 09 Mar 2023 1 $0 4 SVP, Chief Financial Officer 09 Mar 2023, 14:05
AQST Aquestive Therapeutics, Inc. 04 Nov 2022 1 $0 4 SVP, Chief Financial Officer 08 Nov 2022, 09:21
AQST Aquestive Therapeutics, Inc. 10 Mar 2022 1 $0 4 Interim CFO 14 Mar 2022, 11:26
AQST Aquestive Therapeutics, Inc. 15 Jun 2021 1 $0 4 SVP, Chief Financial Officer 17 Jun 2021, 18:51